Descrição:

E3F05 Second Primary Form NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Palavras-chave:

Klinische Studie [Dokumenttyp]

Transferido a:

16 de junho de 2015

DOI:

Para um pedido faça login.

Licença :

Creative Commons BY-NC 3.0 Legacy

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

E3F05 Second Primary Form NCT00978458

INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

StudyEvent: E3F05 Second Primary Form
1. INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

ECOG clinical trial administrative data

ECOG Protocol Number (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

ECOG Patient ID (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

DCI Name

Registration Step

Reporting Period

Second Primary Cancer (Second Primary)

Patient Initials (Last, First)

Participating Group Protocol Number

Institution/Affiliate

Participating Group Patient ID

Data amendment

Please mark an 'X' if data have been amended. (Please circle amended items in red)

Date data amended (s M D Y)

Second primary cancer assessment

Date of Diagnosis of Second Primary Cancer (M D Y)

Site of Second Primary Cancer

Include information on histologic subtype (s Please attach copies of any corroborating pathology reports)

Briefly describe cancer therapy the patient has received prior to the diagnosis of the second primary and other than that given on ECOG protocols

Briefly describe treatment planned or given for the diagnosis of this second primary

Comments

Investigator Signature

Investigator Signature Date (M D Y)

Voltar ao início da página

Similar models

Show recommended models

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.